Melatonin at Night, Caffeine in the Morning: What the New Study Means for Athletic Performance

Table of Contents

1. Key Highlights
2. Introduction
3. The recent trial: design, outcomes, and what the authors reported
4. How caffeine improves performance: mechanisms and practical effects
5. Melatonin’s role: sleep, circadian alignment, and potential recovery effects
6. Parsing causality: was the benefit from caffeine, melatonin, or both?
7. Limitations in the study and why they matter for athletes
8. Practical guidance: who might consider the melatonin–caffeine approach and how to do it safely
9. Dosing examples and timing strategies (practical protocols)
10. Safety, interactions and special populations
11. Real-world examples: how athletes and teams apply caffeine and melatonin today
12. What researchers should do next: study design priorities
13. Translating the evidence to everyday training: a checklist for athletes and coaches
14. FAQ

Key Highlights

• A small, placebo-controlled crossover study found that taking melatonin at night and caffeine the next morning modestly improved high-intensity exercise performance and reduced some markers of muscle damage and inflammation.
• Caffeine is the most likely driver of performance gains via well-established effects on alertness, endurance, reaction time and sprint performance; melatonin’s primary benefit would be through improving sleep and circadian alignment rather than a direct ergogenic effect.
• Evidence remains preliminary: the trial was small, short-term, did not fully isolate each supplement’s effects, and did not control all lifestyle or dietary factors. Strategic timing, dosing, and attention to sleep hygiene remain the practical priorities.

Introduction

Athletes and recreational exercisers routinely look for legal, safe ways to gain a competitive edge. Caffeine occupies a long-established place in sports nutrition for its ability to sharpen focus, delay fatigue, and enhance certain types of exercise when taken before training or competition. A recent placebo-controlled crossover trial has added a new wrinkle: researchers administered melatonin at night and caffeine the following morning and reported a modest uptick in high-intensity exercise performance, plus reductions in some blood markers tied to muscle damage and inflammation.

The headline is simple: pairing nighttime melatonin with morning caffeine improved some outcomes in a limited sample of trained athletes. The nuance matters more. The study raises practical questions about whether the combination produces additive benefits, whether melatonin's effect is mediated solely by improved sleep and recovery, and how coaches, athletes and active adults should interpret a single, small experiment among many variables that influence performance. This article dissects the evidence, explains the physiological mechanisms behind both compounds, highlights limitations, and translates the findings into actionable guidance athletes can use while researchers dig deeper.

The recent trial: design, outcomes, and what the authors reported

Researchers conducted a randomized, placebo-controlled crossover study in trained athletes to test melatonin, caffeine, and their combination on sleep, exercise performance and markers of muscle damage and inflammation. Each participant experienced different interventions in sequence and served as their own control, a design that reduces some inter-subject variability but can still be vulnerable to carryover effects unless washout periods and randomization are rigorous.

Key outcomes reported:

• Slight improvement in high-intensity exercise performance when athletes took melatonin at night and caffeine the next morning compared with placebo.
• Decreases in certain indicators of muscle damage and inflammatory response following the combined intervention.
• No clear evidence in this trial that sleep quality worsened as a consequence of the protocol; however, researchers did not demonstrate robust sleep improvements that would clearly explain the performance changes.

The investigators concluded the combined approach produced modest benefits, but the results need replication in larger, longer trials and in diverse athlete populations.

How caffeine improves performance: mechanisms and practical effects

Caffeine produces performance-enhancing effects through multiple, well-studied pathways. Its primary acute mechanism is competitive antagonism of adenosine receptors in the central nervous system. Adenosine accumulates during wakefulness and physical exertion and promotes sleepiness and perceived fatigue. Blocking adenosine receptors increases neural firing and amplifies the release of neurotransmitters such as dopamine and norepinephrine, promoting alertness and improved mood.

Physiological effects relevant to exercise:

• Reduced perception of effort: At a given workload, athletes report lower ratings of perceived exertion, allowing higher output before subjective fatigue forces them to slow down.
• Increased endurance: Caffeine extends time-to-exhaustion in many endurance tasks and can improve time-trial performance.
• Enhanced sprint and power performance: Evidence supports improvements in repeated sprints and short-duration high-intensity efforts when caffeine is used appropriately.
• Faster reaction times and improved cognitive function: Useful in team sports and precision tasks where split-second decisions matter.

Recommended usage in sports contexts draws on position statements from expert bodies. The International Society of Sports Nutrition (ISSN) recommends an acute dose in the range of approximately 3–6 mg per kg of body weight taken about 30–90 minutes before exercise for reliable ergogenic effects. For a 70 kg athlete, that translates to approximately 210–420 mg of caffeine. Lower doses (e.g., 1–2 mg/kg or 75–150 mg) may also be effective for some individuals and cause fewer side effects; athletes should titrate to effect and tolerance.

Side effects and trade-offs:

• Gastrointestinal upset, jitteriness and increased heart rate at higher doses.
• Anxiety and disturbed sleep if caffeine is consumed late in the day.
• Interindividual variability: habitual caffeine use, genetic differences in caffeine metabolism (CYP1A2) and sensitivity (ADORA2A and other genes) influence response.

Within the trial described earlier, caffeine likely accounted for the main share of observed performance gains. The study’s design—melatonin at night and caffeine the next morning—kept the two separated in time to avoid sleep disruption from morning caffeine, a critical practical point.

Melatonin’s role: sleep, circadian alignment, and potential recovery effects

Melatonin is a hormone produced by the pineal gland that signals biological night and helps synchronize the circadian system. Its primary role is not to act as a direct performance enhancer but to regulate the timing and quality of sleep, which in turn affects recovery, hormonal milieu and readiness for training.

How melatonin supplementation can influence athletes:

• Facilitates sleep onset: Low-to-moderate doses taken 30–60 minutes before bedtime can shorten the time it takes to fall asleep for people with delayed sleep phase or transient difficulties initiating sleep.
• Shifts circadian phase: Timed appropriately, melatonin serves as a chronobiotic, helping reset circadian timing—useful for jet lag, shift work and training schedules that require circadian adjustment.
• Indirectly supports recovery: Better sleep supports glycogen repletion, tissue repair, hormonal recovery (e.g., growth hormone secretion during slow-wave sleep) and psychological readiness.

Potential downsides:

• Next-day grogginess or “hangover” effects at higher doses or when timing is suboptimal.
• Tolerance with prolonged, repeated use in some individuals; endogenous melatonin production may also be suppressed with chronic high-dose use.
• Variable supplement quality and labeling inconsistencies among over-the-counter products.

In the trial that paired melatonin at night with morning caffeine, investigators reported a modest performance benefit and reductions in markers of muscle damage and inflammation. That pattern suggests melatonin might have improved sleep or recovery in ways not fully captured by the trial’s sleep assessments, or that antioxidant and anti-inflammatory properties attributed to melatonin played a role. The latter requires careful scrutiny: melatonin has antioxidant actions in cell and animal models, but translation to clinically meaningful recovery effects in athletes demands larger trials.

Parsing causality: was the benefit from caffeine, melatonin, or both?

The trial’s headline—improved performance after melatonin at night plus caffeine in the morning—does not prove additive synergy. Several alternative explanations exist:

• The caffeine consumed before exercise produced the majority of the ergogenic benefit. The literature supports caffeine’s robust acute effects; a morning dose alone could account for most observed gains.
• Melatonin improved sleep and thereby enhanced recovery for some participants, creating conditions for better output the following day. However, the trial did not document consistent, significant sleep improvements that would unambiguously explain better performance.
• Placebo effects and the controlled environment (wind-down period, controlled timing) may have contributed. When participants are given structured pre-sleep routines and monitored conditions, sleep may improve irrespective of the supplement.
• Uncontrolled dietary variables, participant heterogeneity and small sample size leave room for random variability or confounding.

Experts who commented on the trial emphasized these uncertainties. Samantha Coogan noted that the influence on sleep was not clearly observed in the experiment, making it hard to separate the intervention supplements’ individual contributions. Morgan Walker highlighted that caffeine is likely the strongest driver of performance and that timing separation between nighttime melatonin and daytime caffeine is important to prevent sleep disruption.

A rigorous approach to establishing causality would randomize participants to (1) placebo, (2) melatonin only, (3) caffeine only, and (4) melatonin plus caffeine, with sufficient washout, objective sleep measures (polysomnography or actigraphy), controlled diet, and larger sample sizes. Until such data are available, the combined-intervention result is an intriguing signal but not definitive guidance.

Limitations in the study and why they matter for athletes

Several methodological limitations temper interpretation and translation to practice:

• Small sample size: Small trials are more susceptible to chance findings and less able to detect subgroup effects or rare adverse outcomes. Effect sizes found in small studies often shrink or disappear in larger trials.
• Short duration: Acute or short-term benefits do not guarantee sustainability. A single night of melatonin followed by one morning of caffeine may yield effects that change with repeat use, tolerance development or cumulative sleep debt.
• Sleep assessment: The trial reported no major decline in sleep quality but also did not demonstrate consistent sleep improvement attributable to melatonin. Objective sleep measures were limited or absent, and subjective reports can be biased.
• Lack of full separation of interventions: Without arms for melatonin only and caffeine only (or with insufficient power to analyze them separately), attributing effect to the combination versus caffeine alone is not possible.
• Dietary and lifestyle confounders: Diet, alcohol, training load, and pre-competition routines were not fully controlled. The study included a controlled wind-down period that could itself improve sleep across conditions.
• Participant population: Trained athletes were studied. Results may not generalize to recreational exercisers, older adults, adolescents, or elite competitors whose physiological responses differ.

These limitations matter because athletes and coaches need robust, reproducible evidence before changing practice at scale. Single studies generate hypotheses and inform future research; they rarely constitute the final word.

Practical guidance: who might consider the melatonin–caffeine approach and how to do it safely

Most active adults should prioritize consistent, high-quality sleep and strategic caffeine use rather than relying on supplements as a primary performance lever. The following guidance translates current evidence and expert commentary into practical steps.

1. Prioritize sleep hygiene first

• Regular sleep schedule with consistent bed and wake times supports circadian stability and recovery.
• Limit evening light exposure—particularly blue light from screens—90–120 minutes before bed.
• Create a wind-down routine that includes relaxation, reduced stimulation, and a cool, dark sleeping environment.

2. Use caffeine strategically on competition or high-intensity training days

• Target an acute dose of roughly 3–6 mg/kg body weight about 30–90 minutes pre-exercise for reliable ergogenic effects, per expert consensus. Lower doses may suffice for some.
• Trial caffeine in training before using it in competition to assess side effects (GI upset, anxiety, sleep disturbance).
• Avoid caffeine late in the day when it could reduce sleep quantity or quality.

3. Consider melatonin for circadian realignment or transient sleep-onset problems

• Use low-to-moderate doses (commonly 0.5–3 mg, though some over-the-counter products use higher amounts) timed 30–60 minutes before desired sleep onset when you have difficulty falling asleep or need to shift your schedule (e.g., travel eastward).
• Do not use melatonin routinely to mask chronic poor sleep habits; address underlying causes first.
• Be aware of possible next-day drowsiness and tolerance with repeated use.

4. If experimenting with the combined approach, separate timing

• Take melatonin at night well before bedtime and avoid caffeinated beverages within 8–10 hours of scheduled sleep to protect sleep quality.
• Use caffeine in the morning or pre-exercise window, allowing at least several hours between caffeine intake and sleep. The trial intentionally separated timing to limit sleep disruption.

5. Monitor individual response

• Track sleep with a validated device or sleep diary, and note daytime alertness, mood, training performance and recovery markers.
• Start with conservative doses and adjust based on objective and subjective responses.

6. Consider medical and doping considerations

• Consult a healthcare provider before initiating melatonin or high-dose caffeine, especially if you have cardiovascular disease, anxiety disorders, are pregnant, or take medications that interact with melatonin or caffeine.
• Most sports-governing bodies permit caffeine; however, rules and thresholds vary across disciplines—check relevant anti-doping regulations for in-competition restrictions.

Dosing examples and timing strategies (practical protocols)

Below are example protocols athletes might test under controlled conditions. They are illustrative, not prescriptive.

Example A – Endurance athlete before a morning time trial

• Night before: If sleep onset is problematic or jet lag is present, consider melatonin 0.5–1 mg taken 30–60 minutes before bedtime to facilitate sleep onset and circadian alignment.
• Morning of event: Caffeine 3 mg/kg taken 45–60 minutes pre-start. For a 70 kg athlete, that equals 210 mg (roughly two strong cups of coffee or a 200 mg supplement dose).
• Rationale: Melatonin supports better sleep and recovery; caffeine acutely improves endurance and reduces perceived exertion.

Example B – Team-sport athlete with afternoon training, poor evening sleep

• Night before and routine adjustments: Emphasize sleep hygiene; consider a brief melatonin trial (0.5–2 mg) only if falling asleep is consistently delayed and other strategies have failed.
• Pre-training: Caffeine 2–3 mg/kg 30–60 minutes before the session.
• Rationale: Lower caffeine dose balances alertness benefits and reduced risk of late-day sleep disruption.

Example C – Traveling athlete crossing multiple time zones (eastward travel)

• Pre-travel advice: Use timed melatonin to shift circadian phase for several nights leading into and following travel (timing depends on direction and number of time zones).
• Competition day: Use caffeine strategically on the morning of key sessions or competition after confirming that local sleep has stabilized.
• Rationale: Melatonin is an effective chronobiotic; once local sleep is normalized, caffeine restores acute performance benefits.

Athletes must test these protocols in training to assess tolerability and individualized response. Genetic differences in caffeine metabolism (faster vs. slower metabolizers) influence optimal dosing timing and magnitude.

Safety, interactions and special populations

Safety considerations inform whether to adopt any supplement strategy.

Caffeine safety:

• Generally safe within moderate dosing for most adults. High doses, particularly above 6 mg/kg, are linked to adverse cardiovascular and neuropsychiatric effects in sensitive individuals.
• Interacts with certain medications (e.g., stimulants, some antidepressants) and conditions (pregnancy recommends limiting intake).
• Adolescents and young athletes should use lower doses; many sports medicine guidelines recommend conservative caffeine use in youths.

Melatonin safety:

• Short-term use for circadian realignment or transient insomnia is generally well tolerated.
• Potential interactions with sedatives, anticoagulants, immunosuppressants, and other medications.
• Long-term effects and optimal dosing regimens remain incompletely characterized, and product purity can vary across brands.

Combined use:

• The trial separated timing to reduce interaction risk: melatonin at night, caffeine in the morning. Overlap or inappropriate timing (e.g., caffeine late at night) risks undermining sleep and recovery.
• Both substances can affect mood and arousal in opposite directions; individual responses may vary.

Pregnancy, breastfeeding, children, and certain medical conditions warrant medical consultation before using either supplement.

Real-world examples: how athletes and teams apply caffeine and melatonin today

Several practical examples illustrate how athletes currently use these agents, aligning with the trial’s premise of strategic separation.

1. Marathon runners

• Experienced runners routinely use caffeine gels, chews or beverages before and during races for a performance edge. Many trial caffeine doses in training to find an effective dose that does not upset the stomach. Sleep supplements are rarely part of pre-race strategy except when travel or sleep disturbance is an issue.

2. Team sport athletes

• Soccer and rugby players use moderate-dose pre-match caffeine to sharpen attention and repeated-sprint capacity. Teams working across time zones deploy melatonin selectively to accelerate sleep adaptation in traveling squads ahead of competition.

3. Combat sport athletes and weight-class athletes

• Athletes managing weight cuts may use melatonin to assist with sleep during calorie restriction, when sleep can suffer. Caffeine use is common for increased alertness but must be balanced with potential diuretic and stimulatory effects.

4. Elite cycling teams

• At the professional level, teams employ evidence-based nutritional strategies. Coaches and sports scientists may prescribe melatonin for jet lag management, while caffeine is integrated into race-day fueling plans. Such teams monitor responses meticulously with performance testing and objective sleep measures.

These examples show the practical separation of functions: melatonin for sleep and timing, caffeine for acute performance. The recent trial formalizes a pattern many practitioners already use—timed melatonin for sleep/circadian support combined with morning caffeine for performance—but emphasizes the need for rigorous testing and individualized implementation.

What researchers should do next: study design priorities

To clarify whether melatonin and caffeine together produce additive benefits, researchers should prioritize:

• Larger, well-powered randomized trials with separate arms for melatonin-only, caffeine-only, combination and placebo.
• Objective sleep monitoring (actigraphy, polysomnography) across multiple nights to measure changes in sleep architecture, continuity and circadian timing.
• Standardized diet and hydration control during intervention periods to limit confounders.
• Diverse participant cohorts (elite vs. recreational athletes, different sports, age ranges) to test generalizability.
• Examination of longer-term effects, including tolerance development to melatonin and caffeine’s repeated use.
• Biomarkers beyond general inflammation—detailed cytokine profiling, oxidative stress markers, and muscle recovery indices—coupled with functional performance outcomes.
• Genetic sub-studies (CYP1A2, ADORA2A) to understand interindividual variability in response.

Such work will separate short-term signals from reproducible findings that warrant integration into practice guidelines.

Translating the evidence to everyday training: a checklist for athletes and coaches

Use the following checklist to apply current knowledge responsibly:

• Establish baseline sleep hygiene before supplement trials.
• Track caffeine intake across the day to avoid accumulation and late-day sleep disruption.
• If considering melatonin, test its effect in non-critical training periods first.
• Use caffeine in training before relying on it in competition.
• Document objective and subjective outcomes: training metrics, sleep logs, mood, GI symptoms.
• Adjust doses conservatively and be cautious with high habitual caffeine consumption.
• Consult sports medicine professionals for medical conditions or medication interactions.

Applying the combination—melatonin at night, caffeine in the morning—may be a sensible, low-risk protocol for athletes who already struggle with sleep onset or who must shift their schedules, provided it is implemented with attention to timing and dosing. For athletes with stable sleep, melatonin supplementation may confer little additional benefit.

FAQ

Q: Should every athlete take melatonin at night and caffeine in the morning to boost performance? A: No. The most reliable and broadly applicable strategy remains consistent, high-quality sleep combined with strategic caffeine use before training or competition. The recent trial suggests potential benefit from the melatonin-caffeine combination, but evidence is preliminary. Athletes with sleep-onset problems or circadian misalignment may benefit from timed melatonin; others gain the most from caffeine trials tailored to individual tolerance.

Q: How much caffeine should I take before exercise? A: Expert consensus supports an acute caffeine dose of roughly 3–6 mg per kg of body weight taken 30–90 minutes before exercise for robust ergogenic effects. Lower doses can work for some individuals and reduce side effects. Athletes should test doses in training rather than experimenting on competition day.

Q: What melatonin dose and timing are recommended? A: Effective melatonin doses in practice commonly range from about 0.5 mg to 3 mg taken 30–60 minutes before intended sleep onset. Lower doses are often effective and reduce the risk of next-day drowsiness. Use the smallest effective dose and avoid nightly use without medical guidance.

Q: Will melatonin cancel out caffeine if I take both on the same day? A: Not when taken at separate times. Melatonin administered at night and caffeine the next morning are unlikely to interfere directly, provided caffeine consumption does not occur late enough to disrupt sleep. Overlapping use (e.g., caffeine late evening) increases the risk that caffeine will undermine sleep benefits, negating any advantage from melatonin.

Q: Could melatonin reduce inflammation and muscle damage directly? A: Melatonin has antioxidant and anti-inflammatory properties in preclinical models and some small human studies, but conclusive evidence that melatonin supplementation produces meaningful reductions in exercise-induced muscle damage or faster recovery in athletes is lacking. The recent trial observed reductions in some markers, but those findings require replication and mechanistic clarification.

Q: Are there risks to taking melatonin nightly over long periods? A: Long-term effects of nightly melatonin supplementation are not completely characterized. Some people develop reduced response with repeated use, and high doses can cause daytime drowsiness or potentially interfere with endogenous melatonin production. Consult a healthcare provider for chronic use and if taking other medications.

Q: What about genetic differences in caffeine response? A: Genetic variation in caffeine metabolism (CYP1A2) and sensitivity (e.g., ADORA2A) influences how quickly caffeine is cleared and how strongly it affects sleep and anxiety. Some athletes metabolize caffeine rapidly and tolerate higher doses, while slow metabolizers may experience prolonged stimulation and sleep disturbance. Genetic testing or careful trial-and-error can guide dosing.

Q: Can youth and adolescent athletes use this strategy? A: Caution is warranted. Adolescents are more sensitive to caffeine’s effects, and sleep is especially important during development. If used, caffeine doses should be lower, and melatonin should only be used under medical guidance. Focus on sleep hygiene first.

Q: Should elite sports teams incorporate melatonin-caffeine protocols routinely? A: Teams that regularly manage jet lag or night-to-day transitions may use melatonin strategically for circadian alignment and caffeine for acute performance. However, routine use across all athletes without individualized assessment and monitoring is premature given the current evidence base.

Q: What should researchers focus on next? A: Priority areas include larger randomized trials with separate arms for melatonin and caffeine, objective sleep monitoring, controlled diets and environments, diverse athlete populations, and longer-term follow-up to assess tolerance and real-world effectiveness.

This trial adds nuance to the conversation about sleep, supplements and performance. Caffeine remains a robust, well-documented ergogenic aid when used appropriately. Melatonin’s most defensible role is in managing sleep timing and circadian adaptation, which can indirectly support recovery and readiness. Combining the two with careful timing—melatonin at night, caffeine in the morning—makes physiological sense and produced modest benefits in a small study, but broad adoption should await stronger evidence and individualized testing.